Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sihuan Pharmaceutical Hldgs (460 HK)
Watchlist
46
Analysis
Health Care
•
China
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
20 Aug 2024 16:37
Notice Of Board Meeting
Attachment
Exchange Announcement •
14 Aug 2024 12:12
Voluntary Announcement-Insulin Degludec Injection Huiyouda Developed By Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa
Attachment
Exchange Announcement •
06 Aug 2024 12:02
Voluntary Announcement-Blockbuster Product Insulin Degludec And Insulin Aspart Injection Huiyoujia Developed By Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa
Attachment
Exchange Announcement •
06 Aug 2024 06:08
Voluntary Announcement-Sihuan Pharmaceutical Reached Exclusive Distribution Agreement In Relation To Cartizol, An Intra-Articular Injection Using Collagen, With South Korea Cellontech
Attachment
Exchange Announcement •
27 Jun 2024 12:04
Voluntary Announcement-Calcium Dobesilate Capsules Developed By Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x